🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to compare the efficacy of daratumumab...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2017-11-30
Trial ID
NCT03234972
Treatments Being Tested
This is a multicenter, randomized controlled, open-label study, and the pur...
Status
Unknown
Location
Shanghai Jiaotong University School of Medicine
Start Date
2022-12-08
Trial ID
NCT05432414
Treatments Being Tested
The purpose of this study is to assess the effects of administration of dar...
Status
Completed
Location
Multiple Locations
Start Date
2014-08-15
Trial ID
NCT02136134
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of NOX A12...
Status
Completed
Location
University Hospital Salzburg, Department of Medicine III, Center of Oncology and Hematology
Start Date
2012-03
Trial ID
NCT01521533
Treatments Being Tested
This randomized phase III trial compares bortezomib, dexamethasone, and len...
Status
Terminated
Location
Mayo Clinic in Arizona
Start Date
2007-09
Trial ID
NCT00522392
Treatments Being Tested
The purpose of this study is to compare bortezomib, dexamethasone and cyclo...
Status
Completed
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT00813150
Treatments Being Tested
This is a Phase III Randomized, Controlled, Multicenter, Open-label Study o...
Status
Completed
Location
The First Affiliated Hospital of Anhui Medical University
Start Date
2021-07-12
Trial ID
NCT04939142
Treatments Being Tested
This phase 2 study will be conducted at 10 centers and enroll patients from...
Status
Unknown
Location
Jinling Hospital
Start Date
2013-08
Trial ID
NCT02086942
Treatments Being Tested
This study is designed to evaluate safety and efficacy of belantamab mafodo...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2021-07-28
Trial ID
NCT06868667
Treatments Being Tested
Daratumumab for first line treatment of transplant-ineligible myeloma patie...
Status
Active Not Recruiting
Location
University of Cologne
Start Date
2021-06-01
Trial ID
NCT04656951
Treatments Being Tested